Effect of Hyperhomocysteinemia on Clinical Outcome and Hemorrhagic Transformation After Thrombolysis in Ischemic Stroke Patients

Background and Purpose: Hyperhomocysteinemia (Hhcy) is a well-known risk factor for ischemic stroke. However, the role of Hhcy in the clinical outcome of ischemic stroke has not been fully elucidated. In addition, previous studies have found that Hhcy was implicated in the disruption of the blood-br...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Yun Luo, Hang Jin, Zhen-Ni Guo, Peng Zhang, Li-Yue Zhang, Jie Chen, Yao Yu, Yan Wang, Jie Liu, Qian-Yan He, Xin Sun, Yi Yang
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2019-06-01
סדרה:Frontiers in Neurology
נושאים:
hyperhomocysteinemia
ischemic stroke
recombinant tissue plasminogen activator
intravenous thrombolysis
clinical outcome
hemorrhagic transformation
גישה מקוונת:https://www.frontiersin.org/article/10.3389/fneur.2019.00592/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים